Concert Named a Finalist at CARE Awards for its Commitment to Alopecia Areata

May 6th, 2019

Concert was honored to be a named a finalist for the for the Clinical Research Team of the Year category in the 2019 Clinical & Research Excellence Awards (CARE) Awards. This important award recognizes unsung heroes who work hard to ultimately make human lives better.

“In our efforts to develop CTP-543 for the treatment of alopecia areata, our team’s philosophy is working for the patient, and we are guided by their understanding of the disease condition and the personal impact it has on the individual patient,” said Ginny Braman, Vice President of Clinical Development at Concert Pharmaceuticals.

About CARE Awards

The Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers. Achievements across the spectrum of key R&D activities are celebrated, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and execution.

Back to Top